Athersys
ATHX
#10561
Rank
โ‚ฌ0.7 M
Marketcap
0,01150ย โ‚ฌ
Share price
-33.50%
Change (1 day)
-99.02%
Change (1 year)

Earnings for Athersys (ATHX)

Earnings in 2023 (TTM): -โ‚ฌ38.74 Million

According to Athersys's latest financial reports the company's current earnings are โ‚ฌ0.08 Million. In 2022 the company made an earning of -โ‚ฌ65.58 Million, an increase over its 2021 earnings that were of -โ‚ฌ74.13 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Athersys from 2007 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -โ‚ฌ38.74 Million-40.93%
2022 -โ‚ฌ65.58 Million-11.54%
2021 -โ‚ฌ74.13 Million11.14%
2020 -โ‚ฌ66.7 Million72.2%
2019 -โ‚ฌ38.74 Million77.29%
2018 -โ‚ฌ21.85 Million-22.91%
2017 -โ‚ฌ28.35 Million111.89%
2016 -โ‚ฌ13.38 Million-8.52%
2015 -โ‚ฌ14.63 Million-40.81%
2014 -โ‚ฌ24.71 Million18.62%
2013 -โ‚ฌ20.83 Million
2011 -โ‚ฌ11.74 Million19.71%
2010 -โ‚ฌ9.81 Million-26.28%
2009 -โ‚ฌ13.3 Million-18.21%
2008 -โ‚ฌ16.26 Million-8.28%
2007 -โ‚ฌ17.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚ฌ7.01 B-19,840.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ10.09 B-28,479.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ6.84 B-19,335.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-โ‚ฌ2.68 Billion 7,430.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ27.58 B-77,672.91%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
โ‚ฌ0.14 B-496.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-โ‚ฌ0.54 Billion 1,401.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ19.66 B-55,389.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ7.74 B-21,890.77%๐Ÿ‡ซ๐Ÿ‡ท France